To Vaccinate or not: Influenza Virus and Lung Cancer Progression

Influenza virus infection leads to severe and complicated disease, particularly in patients with lung cancer. It alters the tumor microenvironment (TME), which may potentiate lung cancer progression and disrupt responses to antitumoral treatments. Consequently, influenza vaccination and antiviral tr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Trends in Cancer 2021-07, Vol.7 (7), p.573-576
Hauptverfasser:	Angrini, Mahmud, Varthaman, Aditi, Garcia-Verdugo, Ignacio, Sallenave, Jean-Michel, Alifano, Marco, Cremer, Isabelle
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Cancer Disease Progression Human health and pathology Humans Immunology Influenza A virus - immunology Influenza Vaccines - administration & dosage Influenza, Human - complications Influenza, Human - immunology Influenza, Human - therapy Influenza, Human - virology Life Sciences Lung - immunology Lung - pathology Lung - virology Lung Neoplasms - complications Lung Neoplasms - immunology Lung Neoplasms - mortality Lung Neoplasms - pathology Medical Oncology - standards Practice Guidelines as Topic Pulmonology and respiratory tract Tumor Microenvironment - immunology Vaccination - standards Vaccinology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Influenza virus infection leads to severe and complicated disease, particularly in patients with lung cancer. It alters the tumor microenvironment (TME), which may potentiate lung cancer progression and disrupt responses to antitumoral treatments. Consequently, influenza vaccination and antiviral treatments should be recommended to all patients with lung cancer.
ISSN:	2405-8033 2405-8025
DOI:	10.1016/j.trecan.2021.02.006